These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
611 related items for PubMed ID: 22095236
1. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy. Shahni R, Gnudi L, King A, Jones P, Malik AN. Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236 [Abstract] [Full Text] [Related]
2. Nop-7-associated 2 (NSA2), a candidate gene for diabetic nephropathy, is involved in the TGFβ1 pathway. Shahni R, Czajka A, Mankoo BS, Guvenel AK, King AJ, Malik AN. Int J Biochem Cell Biol; 2013 Mar; 45(3):626-35. PubMed ID: 23220173 [Abstract] [Full Text] [Related]
3. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R. FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073 [Abstract] [Full Text] [Related]
4. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M. Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917 [Abstract] [Full Text] [Related]
5. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy. Carmona M, Paco-Meza LM, Ortega R, Cañadillas S, Caballero-Villarraso J, Blanco A, Herrera C. Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832 [Abstract] [Full Text] [Related]
6. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Klemis V, Ghura H, Federico G, Würfel C, Bentmann A, Gretz N, Miyazaki T, Gröne HJ, Nakchbandi IA. Kidney Int; 2017 Jun; 91(6):1374-1385. PubMed ID: 28159318 [Abstract] [Full Text] [Related]
7. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK. Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964 [Abstract] [Full Text] [Related]
8. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy. Ma J, Wu H, Zhao CY, Panchapakesan U, Pollock C, Chadban SJ. Int J Clin Exp Pathol; 2014 Nov; 7(2):481-95. PubMed ID: 24551269 [Abstract] [Full Text] [Related]
9. Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1. Zhang L, He S, Guo S, Xie W, Xin R, Yu H, Yang F, Qiu J, Zhang D, Zhou S, Zhang K. J Diabetes Complications; 2014 Nov; 28(3):259-64. PubMed ID: 24560136 [Abstract] [Full Text] [Related]
10. DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance. Østergaard MV, Pinto V, Stevenson K, Worm J, Fink LN, Coward RJ. Am J Physiol Renal Physiol; 2017 Feb 01; 312(2):F312-F321. PubMed ID: 27852608 [Abstract] [Full Text] [Related]
11. A protective role of renalase in diabetic nephropathy. Yin J, Liu X, Zhao T, Liang R, Wu R, Zhang F, Kong Y, Liu L, Xing T, Wang N, Zhao Q, Wang F. Clin Sci (Lond); 2020 Jan 17; 134(1):75-85. PubMed ID: 31899483 [Abstract] [Full Text] [Related]
12. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Fujii M, Inoguchi T, Maeda Y, Sasaki S, Sawada F, Saito R, Kobayashi K, Sumimoto H, Takayanagi R. Kidney Int; 2007 Aug 17; 72(4):473-80. PubMed ID: 17568784 [Abstract] [Full Text] [Related]
13. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway. Wang H, Huang X, Xu P, Liu X, Zhou Z, Wang F, Li J, Wang Y, Xian X, Liu G, Huang W. Metabolism; 2021 Jun 17; 119():154740. PubMed ID: 33639183 [Abstract] [Full Text] [Related]
14. Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy. Choi S, Hong SP, Bae JH, Suh SH, Bae H, Kang KP, Lee HJ, Koh GY. J Am Soc Nephrol; 2023 May 01; 34(5):809-828. PubMed ID: 36724799 [Abstract] [Full Text] [Related]
15. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy. Lu Q, Zhou Y, Hao M, Li C, Wang J, Shu F, Du L, Zhu X, Zhang Q, Yin X. Mol Cell Endocrinol; 2018 Sep 15; 473():31-43. PubMed ID: 29277549 [Abstract] [Full Text] [Related]
16. Renal endothelial protein C receptor expression and shedding during diabetic nephropathy. Lattenist L, Ochodnický P, Ahdi M, Claessen N, Leemans JC, Satchell SC, Florquin S, Gerdes VE, Roelofs JJ. J Thromb Haemost; 2016 Jun 15; 14(6):1171-82. PubMed ID: 26990852 [Abstract] [Full Text] [Related]
17. Urocortin ameliorates diabetic nephropathy in obese db/db mice. Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S. Br J Pharmacol; 2008 Jul 15; 154(5):1025-34. PubMed ID: 18587447 [Abstract] [Full Text] [Related]
18. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis. Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E, Wanke R. Am J Physiol Renal Physiol; 2009 Apr 15; 296(4):F819-29. PubMed ID: 19211686 [Abstract] [Full Text] [Related]
19. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy. Yung S, Chau MK, Zhang Q, Zhang CZ, Chan TM. PLoS One; 2013 Apr 15; 8(1):e54501. PubMed ID: 23349910 [Abstract] [Full Text] [Related]
20. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, Panagiotopoulos S, McNeil K, Baker ST, Fioretto P, Macisaac RJ. Diabetes Care; 2013 Nov 15; 36(11):3620-6. PubMed ID: 23835690 [Abstract] [Full Text] [Related] Page: [Next] [New Search]